Xemio, an app to help women undergoing breast cancer treatment, is born - #BHHMembersInitiatives
Home News Xemio, an app to help women undergoing breast cancer treatment, is born - #BHHMembersInitiatives

Xemio, an app to help women undergoing breast cancer treatment, is born - #BHHMembersInitiatives

FEBRUARY 1, 2022 Members' News
BHH member the iSYS Foundation, dedicated to carrying out digital health social projects, has developed the Xemio app to accompany people undergoing breast cancer treatment. It is an app designed to help patients with any doubts they may have, offering specific, rigorous and up-to-date information to help them understand what is happening to them. It contains a list of more than fifty common side effects of the treatments, medical scales for objective assessment of their intensity and hygiene and dietary advice. The aim of this tool is to help patients with tailor-made information to lower their anxiety levels when they are at home during cancer treatment. Xemio was born from the personal experience of Imma Grau, president of the Foundation, engineer and social researcher, who was diagnosed with breast cancer in 2012. Aware of the importance of having information, just when it is needed, to reduce anxiety levels, she decided to develop Xemio and thus help other people who were in the same situation. During the growth of the project, Dr. Montserrat Muñoz, oncologist and editor of Xemio, has supervised all the scientific content. The development of the current version of the Xemio app has been made possible thanks to a grant from the Caixa Foundation, an European H2020 grant and micro-patronage. The app makes it easier for patients to carry out their own monitoring, provides information on dozens of side effects, allows them to determine their intensity (mild, moderate or severe according to CTCA standards), provides hygienic-dietary advice and facilitates their registration. The information is complementary to healthcare and in no case replaces the information provided by healthcare professionals. The record of the adverse effects suffered in a period can be downloaded in pdf format, to be shared during the medical visit, thus promoting patient empowerment. In addition, the application is designed with technological standards in order to integrate with different health information systems and make it easier for clinicians to carry out real-life monitoring. Exercise has been proven to be beneficial in improving the side effects of breast cancer treatments. Therefore, the app tracks daily steps to promote physical activity. Patients will get information about the average steps of other app users, compare themselves with people in the same situation and read advice from health professionals and the WHO. Until now, the Xemio app has only been available to participants in a pilot study that is part of a European Horizon H2020 research project, called ASCAPE. The aim of ASCAPE is to use artificial intelligence to improve patients' quality of life. The Barcelona pilot involves the iSYS Foundation, the Hospital Clínic de Barcelona and the FCRB. The app is currently available for free download on Android and iOS mobile phones worldwide. More information can be found here!
October 05, 2026 Members' News
MSD in Spain joins Barcelona & Madrid Health Hub to drive digital health innovation
MSD in Spain has signed an agreement to join Barcelona & Madrid Health Hub, taking another step forward in its commitment to digital health innovation, an area in which the Company has been working for some time.
Read more
September 21, 2026 Members' News
Sykah introduces virtual workers that eliminate administrative burden from pharma companies
Today, in most plants, admin work eats the real work. Incident reports on paper. Data copied by hand between excels. Hours of process documentation nobody has time to maintain. The result: skilled technicians doing office work, and decisions made late or on incomplete information.
Read more
September 21, 2026 Members' News
Skinive expands AI-powered skin analysis platform with new UV Protection & Monitoring features
Barcelona, Spain Skinive, a member of Barcelona Health Hub, has announced a major update to its AI-powered skin health platform with the launch of new UV Protection & Monitoring features for iOS and Android. The latest release helps people better understand daily ultraviolet (UV) exposure and make more informed decisions about sun protection during periods of high UV radiation and extreme summer temperatures.
Read more
September 11, 2026 Members' News
AMConsulting Medical Devices will be at Farmaforum 2026
On September 22 and 23, Farmaforum will bring together companies, professionals, and innovative projects from the pharmaceutical, biotechnology, and medical device sectors at IFEMA Madrid.
Read more
September 11, 2026 Members' News
Barcelona Health Hub Member InnHealthium Helps MedTech Companies Prepare for the EU AI Act
Barcelona Health Hub member InnHealthium is bringing together experts in AI-enabled medical devices, standards development, QA/RA and conformity assessment for a dedicated event at Barcelona Health Hub on September 22, helping the MedTech ecosystem prepare for the practical impact of the EU AI Act.
Read more
July 17, 2026 Members' News
IDEA Design reaches a new European milestone in healthcare design
IDEA Design has reached a new milestone in the iF Design Ranking 2022–2026, placing 11th among 76 European design and architecture studios in the Medical/Healthcare category, and ranking as the leading Spanish company in this classification.
Read more
July 15, 2026 Members' News
A Faster Route from Digital Health Idea to Patient Impact
Maze Interactive Health is helping healthcare organisations design,  build and scale intelligent digital solutions without the delay, cost  and complexity of starting from scratch.
Read more
July 15, 2026 Members' News
Time is Brain oversubscribes a €3 million funding round and obtains CE/MDR approval to accelerate the adoption of Real-Time Stroke Intelligence in Europe
Barcelona, Spain – July 9, 2026 – Time is Brain, a pioneer in the emerging category of Real-Time Stroke Intelligence, today announced two key milestones supporting its commercial expansion across Europe: the oversubscription of a €3 million Pre-Series A funding round and the CE/MDR approval of its flagship BraiN20® Real-Time Stroke Intelligence platform.
Read more
July 15, 2026 Members' News
Vall d’Hebron and Barcelona & Madrid Health Hub Renew Their Collaboration to Advance Digital Health Innovation
The renewed agreement will enable both organizations to continue working together to accelerate digital health innovation and support the adoption of new technologies across the healthcare system.
Read more
July 10, 2026 Members' News
Tandem introduces AI-powered clinical decision support for faster, evidence-based care
The new solution enables healthcare professionals to receive source-linked clinical answers in seconds while documenting the patient consultation.
Read more